Filing Flows › Outset Medical (OM) › Q1 2026
Outset Medical (OM) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Outset Medical (OM) reported revenue of $27.9M for the first quarter 2026 (Q1 2026), -6% from a year earlier and -4% from the quarter before. Operating margin was -60.7%, net loss $19.0M (68.1% of revenue).
Outset Medical, Q1 2026: revenue $27.9M (-6% year over year), operating margin -60.7%, net loss $19.0M, operating cash flow −$12.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.9M | -4% | -6% |
| Operating profit | −$16.9M | — | — |
| Net earnings | −$19.0M | — | — |
| Operating cash flow | −$12.8M | — | — |
What changed
Revenue was $27.9M in Q1 2026, down 6% year over year and down 4% from the previous quarter. Consumables Product was the largest line at 47% of revenue. Consoles Product lost $1.7M year over year (down 24%), 91% of the total change.
Gross margin was 43.4%, up 6.2 points from Q1 2025. Operating costs exceeded revenue by $16.9M, an operating margin of -60.7%. Operating expenses grew 6% against a revenue fall of 6%. The fastest-growing cost line was General & admin (+22%). The quarter ended with a net loss of $19.0M, narrower than the previous quarter's $19.5M loss.
Operating cash flow was −$12.8M. Non-cash charges added back $795K of depreciation and amortization and $3.5M of share-based compensation. Working capital and other items added $1.9M. Capital expenditures of $65K exceeded it, leaving free cash flow of −$12.9M.
Questions
What was Outset Medical's revenue in the first quarter 2026?
Outset Medical (OM) reported revenue of $27.9M for the first quarter 2026 (Q1 2026), -6% from a year earlier and -4% from the quarter before.
Was Outset Medical profitable in the first quarter 2026?
Operating loss was $16.9M (-60.7% of revenue) and net loss $19.0M.
Source: Outset Medical 10-Q on SEC EDGAR.